CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: cefuroxime
Accession: CHEBI:3515
browse the term
Definition: A 3-(carbamoyloxymethyl)cephalosporin compound having a 7-(2Z)-2-(furan-2-yl)-2-(methoxyimino)acetamido side chain.
Synonyms: exact_synonym: 3-[(carbamoyloxy)methyl]-7beta-[(2Z)-2-(furan-2-yl)-2-(methoxyimino)acetamido]-3,4-didehydrocepham-4-carboxylic acid
related_synonym: (6R,7R)-3-[(carbamoyloxy)methyl]-7-{[(2Z)-2-furan-2-yl-2-(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; Cefuroxim; Cephuroxime; Formula=C16H16N4O8S; InChI=1S/C16H16N4O8S/c1-26-19-9(8-3-2-4-27-8)12(21)18-10-13(22)20-11(15(23)24)7(5-28-16(17)25)6-29-14(10)20/h2-4,10,14H,5-6H2,1H3,(H2,17,25)(H,18,21)(H,23,24)/b19-9-/t10-,14-/m1/s1; InChIKey=JFPVXVDWJQMJEE-IZRZKJBUSA-N; SMILES=[H][C@]12SCC(COC(N)=O)=C(N1C(=O)[C@H]2NC(=O)C(=N/OC)\\c1ccco1)C(O)=O; Sharox; Zinacef Danmark; cefuroximo; cefuroximum
xref: CAS:55268-75-2; DrugBank:DB01112; Drug_Central:565; KEGG:C06894; KEGG:D00262
xref_mesh: MESH:D002444
xref: MetaCyc:CPD0-2069; PMID:11168076; PMID:11322179; PMID:11581233; PMID:12141712; PMID:12235459; PMID:12833570; PMID:12898829; PMID:14658923; PMID:15052582; PMID:15828440; PMID:16341950; PMID:17111749; PMID:17113884; PMID:17261579; PMID:17366015; PMID:17676080; PMID:18208759; PMID:18611587; PMID:18795089; PMID:18931469; PMID:19069618; PMID:19142482; PMID:19411164; PMID:21425867; PMID:29017833; Patent:DE2439880; Patent:DE2706413; Patent:US3974153; Patent:US4267320; Reaxys:5783190; Wikipedia:Cefuroxime
G
Cat
catalase
decreases activity
EXP
Cefuroxime results in decreased activity of CAT protein
CTD
PMID:30797828
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
G
Il10
interleukin 10
multiple interactions
ISO
Cefuroxime inhibits the reaction [Lipopolysaccharides results in increased secretion of IL10 protein]
CTD
PMID:16939481
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
G
Nfe2l2
NFE2 like bZIP transcription factor 2
decreases activity
ISO
Cefuroxime results in decreased activity of NFE2L2 protein
CTD
PMID:30203046
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
G
Nr1i3
nuclear receptor subfamily 1, group I, member 3
decreases activity
ISO
Cefuroxime results in decreased activity of NR1I3 protein
CTD
PMID:30203046
NCBI chr13:83,632,940...83,638,193
Ensembl chr13:83,632,899...83,637,906
G
Ppara
peroxisome proliferator activated receptor alpha
decreases activity
ISO
Cefuroxime results in decreased activity of PPARA protein
CTD
PMID:30203046
NCBI chr 7:116,832,405...116,900,878
Ensembl chr 7:116,832,756...116,895,346
G
RT1-A2
RT1 class Ia, locus A2
affects expression
ISO
Cefuroxime affects the expression of HLA-E mRNA
CTD
PMID:25811541
NCBI chr20:4,870,939...4,910,183
G
RT1-Bb
RT1 class II, locus Bb
affects expression
ISO
Cefuroxime affects the expression of HLA-DQB1 mRNA
CTD
PMID:25811541
NCBI chr20:4,596,558...4,602,201
Ensembl chr20:4,596,559...4,607,597
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all